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The study tried to assess the chemoprotective eﬀect of abnormal Savda Munziq (ASMq) on 1,2-dimethylhydrazine (DMH)-
induced rat colon carcinogenesis. Male F344 rats were randomized into eight groups: Group 1 was served as control, no DMH
injection was given and treated daily with normalsaline. Rats in Groups 2–8 were given a single intraperitoneal injection of DMH
(20mg/kg body weight) at the beginning of the study. Group 2 was served as negative control, administered with normal saline
until the end of the experiment after the single DMH injection. Groups 3–5 were served as pretreatment group, administered
with ASMq ethanol extract at 400, 800 and 1600mg/kg body weight, respectively, until the 45th day, continued by normal saline
administration for another 45 days. Groups 6–8 were served as the treatment group, administered with normal saline for the
ﬁrst 45 days from the day of DMH injection, ASMq ethanol extract at three diﬀerent doses to be administered until the end of the
second45thday.Allratswere sacriﬁcedat91stdayandthecolonswere analyzedforaberrantcrypt foci(ACF)formationandcrypt
multiplicity. Results showed that ASMq ethanol extract reduced the number of ACF, AC and crypt multiplicity signiﬁcantly (P <
.05). It suggested that ASMq ethanol extract had chemoprotective eﬀects on DMH-induced colon carcinogenesis, by suppressing
the development of preneoplastic lesions, and probably exerted protection against the initiation and promotion steps of colon
carcinogenesis.
1.Introduction
Abnormal Savda Munziq (ASMq), one of the Uighur
m e d i c i n a lh e r b a lp r e p a r a t i o n s, is widely distributed in the
Xinjiang regionofChina. Ithas longbeenusedinTraditional
UighurMedicinefor the treatment ofseveral diseases such as
digestive cancer, diabetes, cardiovascular diseases or chronic
asthma [1]. It is regularly used by Uighur physicians for
the treatment of cancer, and in southern Xinjiang many
ordinary people regularly self-medicate with it to prevent
cancers. To date, these putative anticancer eﬀects of ASMq
havebeenlittlestudiedanditspotentialmechanism ofaction
is still unclear. A possible anticancer eﬀect of ASMq clearly
warrants further investigation. In our previous studies,
ASMq was proved to possess strong free radical scavenging
eﬀects, and decreased biological markers of oxidative stress
in man [1], protected mitochondria and DNA against OH-
induced oxidative damage in a cell-free system [2, 3],
inhibited cancer cells proliferation and viability in vitro [4].
Colon cancer is one of the most common malignancies
in many regions of the world and is thought to arise
from the accumulation of mutations in a single epithelial
cell of the colon and rectum [6]. Aberrant crypt foci
(ACF), a colon carcinoma precursor in humans and rats,
is selected as one of the feasible tools and as a sensitive,
reliable and rapidly appearing biomarker, supported by the
presence of histopathologic intraepithelial neoplasia [7].
Pereira et al. [8] evaluated the ability of a substance to
reduce the yield of azoxymethane (AOM)-induced foci in
the colon of male Fischer 344 rats as a screening assay for2 Evidence-Based Complementary and Alternative Medicine
Table 1: Herbal compositionof ASMq [4, 5].
Plant name Family name Uighur name Used parts
Adiantum capillus-veneris L. Adiantaceae Pirsiyavxan Whole plant
Alhagi pseudoalhagi Desv. Fabaceae Yantak xikiri Branch secretion
Anchusa italica Retz. Boraginaceae Gavzivan Aerial parts
Cordia dichotoma G.Forst. Boraginaceae Serpistan Fruit
Euphorbia humifusa Willd. Euphorbiaceae Xahtere Whole plant
Foeniculum vulgare Mill. Apiaceae Arpabidiyan Fruit
Glycyrrhiza uralensis Fisch. Fabaceae Q¨ uq¨ uk buya yiltizi Radix or rhizoma
Lavandula angustifolia Mill. Lamiaceae ¨ Ustihuddus Aerial parts
Melissa oﬃcinalis L. Lamiaceae Badrenjibuya hindi Whole plant
Ziziphus jujuba Mill. Rhamnaceae Qilan Fruit
chemopreventive agents, and demonstrated that the ACF
might be a useful biomarker to detect possible eﬀects of a
chemopreventive agent in rat colon carcinogenesis. In the
past several years, a number of chemical carcinogens such
as 1,2-dimethylhydrazine (DMH), AOM, 2-amino-3-methyl
imidazole quinoline, methylnitrosurea, N-methyl-N-nitro-
N-nitrosoguanidine have been used to induce benign and
malignant neoplasm in the colon of the rodents. These
agents have provided a reasonably accurate experimental
model of human colon cancer [9, 10]. One such chemical
DMH, a potent and complete carcinogen, has been reliably
used to induce initiation and promotion steps of colon
carcinogenesis in rodents. DMH and related compounds
induceneoplasmspeciﬁcallyincolonofratevenafterasingle
dose[11,12].MetabolicactivationofDMHtohighlyreactive
electrophiles (methyldiazonium ion) occurs in the liver and
colon. However, the main target organ of DMH is the large
intestine [9].
As a number of natural compounds prevent colon
carcinogenesis in rodents by inhibition of ACF development
[13–21], the present study was designed to determine the
potential chemopreventive eﬀects of ASMq ethanol extract
against the development of colonic ACF in an experimental
model of colon carcinogenesis induced by DMH treatment
in the rats.
2.MaterialandMethods
2.1. Animals. Rats were fed according to ethical standards
of animal research committee of the Xinjiang autonomous
r e g i o n .At o t a lo f6 4m a l e6 - w e e k - o l dF 3 4 4r a t s ,w e i g h i n g
180–200g, were obtained from Harlan (Gannat, France).
The animals were kept in polypropylene cages (four animals
per cage) on hard wood chips as bedding, and covered
with metallic grids in a room maintained at 25 ± 3◦C,
50 ± 10% humidity and with a 12-h light–dark cycle. They
were fed commercial chow (standard powdered diet for
rodent maintenance, 9609 Harlan Teklad, Gannat, France)
a n dp r o v i d e dt a pw a t e rad libitum.
2.2. Chemicals. DMH was obtained from Fluka Sigma-
Aldrich (Switzerland), and dissolved in 0.9% NaCl at a
concentration of 2mg/mL and adjusted to pH 6.8 with
1M NaOH. Formalin solution (10%, neutral buﬀered) and
methylene blue were obtained from Sigma-Aldrich (Lyon,
France). All other chemicals were of reagent grade.
2.3. Preparation of Ethanol Extract of ASMq. ASMq was
composedof10kindsofherbalmedicinalplantsasdescribed
in Table 1. Plant materials were purchased from Xinjiang
Hospital of Traditional Uighur Medicine (Urumqi 830001,
P.R. China). Voucher specimens have been deposited in the
Herbarium of Xinjiang Institute of Ecology and Geography,
Chinese Academy of Sciences (Urumqi 830011, P.R. China).
All herbal materials were authenticated from Xinjiang
Institute for Drug Control (Urumqi 830002, P.R. China).
Herbalmedicineswereselectedaccordingtotheusualrecipes
recommended by Upur and Yusup [5] and prepared by
a professional pharmacist. Brieﬂy, herbs were minced and
circulated with 95% ethanol in the proportion of 1:10 (w/v)
for 5h and repeated for additional three times for 4h after
adding the same amount of ethanol. The resulting crude
extracts were ﬁltered and distilled to oiliness form, and
degreased with petroleum ether after dissolving in proper
volume of hot water. Remaining water-soluble extract was
vacuum dried (Buchi, Switzerland) to powder and kept at
4◦C for future use. Extract yield of plant material was 12%
(w/w). In this experiment, the dried powder was dissolved in
distilled water as a 1600mg/mL (dry weight of the extract)
stock solution and could be kept at −20
◦C for 3 months
without loss of any eﬀect. The other concentrations used
in the experiment were prepared by adding distilled water
weekly.
2.4. Experimental Design. After 1 week of acclimatization,
animals were randomly divided into eight groups each
containing eight rats (Figure 1): Group 1 was served as
control, no DMH injection, treated daily with normal saline
at 10mL/kg body weight until the end of the study. Rats in
Groups 2–8 were given a single intraperitoneal injection of
DMH (20mg/kg body weight) at the beginning of the study.
Rats in Group 2, served as negative control, in addition to
DMH injection, were administered normal saline once a day,
during the experimental period. Rats in Groups 3–5 served
as pretreatment group, ASMq ethanol extract at 400, 800
and 1600mg/kg body weight were administered by gavageEvidence-Based Complementary and Alternative Medicine 3
Table 2: Eﬀect of ASMq ethanol extract on ACF formationin DMH-treated rats (mean ± SD).
Group/treatment Number of rats ACF formationin rat colon
Total AC Total ACF
Normal control (NS) 8 0 0
Negative control (DMH + NS) 8 129.8 ± 43.75 0 .3 ±16.8
Pretreatment (DMH + ASMq 400) 8 105.1 ±60.9
∗ 41.9 ±20.5
∗
Pretreatment (DMH + ASMq 800) 8 91.5 ±37.4
∗ 38.8 ±14.1
∗
Pretreatment (DMH + ASMq 1600) 8 53.4 ±31.8
∗ 23.0 ±14.0
∗
Treatment (DMH + ASMq 400) 8 91.8 ±33.6
∗ 35.9 ±11.8
∗
Treatment (DMH + ASMq 800) 8 81.5 ±39.5
∗ 31.0 ±14.8
∗
Treatment (DMH + ASMq 1600) 8 46.0 ±25.8
∗ 22.4 ±9.3
∗
∗P<. 05 as compared with negative control group.
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Figure 1: Experimental design to evaluate the eﬀect of ASMq
ethanol extract on DMH-induced ACF in the rat colon. Open
square: normal saline, yellow square: ASMq administration by
gavage, DMH treatment: 20mg/kg body weight intraperitoneal
injection,s:sacriﬁceat91stday,n:numberofanimals/group,Group
1: normal control, no treatment, Group 2: negative control, DMH
alone, Groups 3–5: pretreatment, ASMq at three diﬀerent doses
(400,800and1600mg/kg,resp.) andGroups 6–8:treatment, ASMq
at three diﬀerent doses (same as pretreatment group).
once a day, respectively, after the DMH injection until the
end of ﬁrst 45 days, and then continued by normal saline
administration for another 45 days. Rats in groups 6, 7 and
8,served astreatment groups,and administered with normal
saline for the ﬁrst 45 days from the day of DMH injection,
subsequently, ASMq ethanol extract at three diﬀerent doses
(400, 800 and 1600mg/kg body weight, by gavage) were
administered, respectively, until the end of second 45 days.
The animals were weighed once a week throughout the
experimental period, and the dose volumewas adjusted once
weekly based on body weight. The administration procedure
was completed in 90 days after the DMH injection.
2.5. Tissue Processing, Identiﬁcation and Quantiﬁcation of
ACF. Diets were removed 24h prior to sacriﬁce, and all rats
were sacriﬁced under ether anesthesia at 91st day after the
start of the experiment. The colons were removed, cleaned
with saline solution (0.9%) and slit open longitudinally
from cecum to anus. Each colon was cut into proximal,
middle and distal portion of equal length, and ﬁxed ﬂat
between two pieces of ﬁlter paper in 10% neutral-buﬀered
formalin for at least 24h. Later, they were stained with 5%
methylene blue for 5–10min, and they were then placed on
a microscopic slide; the mucosal side was observed through
light microscope at 40x magniﬁcations. ACF were counted
by the method of Bird [22]. Crypts or distinct foci of crypts
were counted as an ACF if they displayed at least two of the
following characteristics [17]: (i) occupy a greater area than
surrounding crypts; (ii) have a thickened epithelial lining;
(iii) have elongated or altered shape of luminal opening; and
(iv) have an increased pericryptal zone separating the crypt
or foci from surrounding crypts. The total number of ACF
and the number of crypts/ACF (multiplicity) were scored
b l i n d l yb yas i n g l eo b s e r v e r .
2.6. Statistical Analysis. All data were presented as the
mean ± SD. The statistical analysis was accomplished using
SPSS 10.0 software package by one-way analysis of variance
(ANOVA) and Student’s t-test. Diﬀerences were considered
as statistically signiﬁcant at P<. 05.
3.Results
3.1. Inhibitory Eﬀect of ASMq Ethanol Extracts on Rat Colon
ACF, AC Formation. All rats in Groups 2–8 developed colon
ACF and AC at the end of the experiment. The number of
colon ACF and AC per rat of negative control was 50.3 ±
16.8 and 129.8 ± 43.7, respectively. Administration of ASMq
ethanol extracts either pretreatment or treatment caused a
signiﬁcant inhibition of colon ACF and AC formation in
a dose-response relationship when compared with negative
control group (P<. 05) (Table 2).
3.2. Inhibitory Eﬀect of ASMq Ethanol Extracts on Aberrant
Crypt Multiplicity. ThenumberofACFconsisting morethan
four aberrant crypts per rat of negative control(11±3.9)was
signiﬁcantly higher than those of pretreatment or treatment
groups (P<. 05). As far as aberrant crypt multiplicity4 Evidence-Based Complementary and Alternative Medicine
Table 3: Eﬀect of ASMq ethanol extract on aberrant crypt multiplicity in DMH-treated rats (mean ± SD).
Groups/treatment Number of rats ACF ≤ 3A C F ≥ 4A C / A C F
Normal control (NS) 8 0 0 —
Negative control (DMH + NS) 8 39.3 ±14.31 1 .0 ± 3.92 .6 ±0.2
Pretreatment (DMH + ASMq 400) 8 32.9 ±14.29 .0 ±7.3
∗ 2.4 ±0.4
∗
Pretreatment (DMH + ASMq 800) 8 32.3 ±11.26 .5 ±3.3
∗ 2.3 ±0.2
∗
Pretreatment (DMH + ASMq 1600) 8 19.6 ±12.5
∗ 3.4 ±2.9
∗ 2.3 ±0.5
∗
Treatment (DMH + ASMq 400) 8 27.8 ±9.0
∗ 8.1 ±3.3
∗ 2.5 ±0.2
Treatment (DMH + ASMq 800) 8 24.6 ±13.3
∗ 6.4 ±4.1
∗ 2.6 ±0.4
Treatment (DMH + ASMq 1600) 8 19.9 ±7.3
∗ 2.5 ±2.9
∗ 2.0 ±0.4
∗
∗P<. 05 as compared with negative control group.
(AC/ACF) was concerned, crypt multiplicity of negative
control (2.6 ± 0.2) was signiﬁcantly higher than those of
all three pretreatment groups (P<. 05). Only the high-
dose treatment group (1600mg/kg of ASMqethanol extract)
succeeded to decrease the crypt multiplicity in DMH-treated
rats (P<. 05) (Table 3). A similar tendency was observed for
ACF in less than three aberrant crypts/rats.
4.Discussion
Biochemical, genetic and morphologic studies have shown
that ACF and colon tumors share similar alterations, further
supporting the hypothesis that the ACF are precursors of
colorectal cancer [23–25]. A number of natural compounds
that inhibit ACF development have been proved to prevent
colon cancer in rodents [13–21, 26–28]. Thus, the ACF
assay, using the complete colon carcinogen DMH, has been
proposed to evaluate chemopreventive agents for colon
carcinogenesis in rats [29–31]. The purpose ofthis study was
basically to investigate the eﬀect of ASMq ethanol extract on
the rat colon carcinogenesis induced by DMH, as evaluated
by ACF development.
Recent studies suggested that in vitro anticancer proper-
ties of ASMq ethanol extract and aqueous extract relate to
the inhibition of cell proliferation or cell death triggered by
eithernecrosis(LDHleakage)orapoptosis(caspase-3activa-
tion).Severalcellulartargetssuchascellularmacromolecules
are impacted by the active molecules. Indeed protein, DNA
and RNA synthesis are inhibited [32]. Either related or
not a caspase-3-dependent apoptosis is induced, which is
also characterized by cell cycle arrest in Sub-G1 phase,
downregulation of p53, p21 and bcl2 and upregulation of
bax—all shown at transcriptional level in the HepG2 cell line
ofhuman liver, which still bears a normal regulating capacity
of the p53 gene. Concomitantly, the herbal preparation
stronglypreventstheindirecteﬀectsofoxidativestress onthe
DNA such as formation of oxidized DNA bases (8OH-dG)
and/or methylated bases such as m5dC. These eﬀects could
be regarded as the prevention by ASMq of an epigenetic
pathway also leading possibly to cancer [4, 33]. The active
ingredients in ASMq that exerted the anticancer eﬀect in
vitro on Hep-G2 cells have not been fully clariﬁed, but the
ethyl acetate extract as well as total ﬂavonoids of ASMq have
shown a remarkable cytotoxicity and apoptosis-induction
potential in this human hepatoma (HepG2) cell line [34].
Our present results showed that the pretreatment as well
as the treatment of ASMq ethanol extract suppressed the
development of ACF, AC and crypt multiplicity induced by
DMH single injection at all three doses tested. Especially
large ACF (four or more) were signiﬁcantly inhibited after
45 days of pretreatment or treatment with ASMq ethanol
extract, since larger ACF (four or more aberrant crypts
per focus) have been considered more likely to progress to
tumors [35–37]. Our results also showed that the inhibitory
eﬀect of ASMq ethanol extract in the treatment group
seemed to be more evident than that of pretreatment group.
Carcinogenesis is a multistep process, involving initiation,
promotion and progression. According to the literature, the
increased number of ACF may reﬂect the initiation step
of colorectal carcinogenesis, while the progressive increase
in the number of crypts per ACF may correspond to the
promotion step of colon tumorigenesis [23, 35, 38–40].
These results indicated that ASMq ethanol extract was able
to inhibit the initiation and promotion steps of colon
carcinogenesis in rodents.
Other chemopreventive agents with antioxidant proper-
ties have been found to inhibit DMH- and AOM-induced
colon carcinogenesis and DNA damage in animal model
[13, 15, 41, 42]. Although the mechanisms involved in
the inhibitory eﬀects of ASMq ethanol extract against ACF
formation are not clearly understood, it could be explained
by its putative antioxidant activity [43]a n dp r o t e c t i v ee ﬀects
to oxidative stress induced DNA and mitochondrial damage
[2, 3]. Since DMH is an indirect carcinogen, which has
to be metabolized to exert its carcinogenic eﬀect, it could
be postulated that ASMq ethanol extract has interference
on DMH metabolic pathways. Also, the presence of dose-
response relationship observed in the current study could be
attributedtothesynergisticactivityofcongenericordiﬀerent
compounds increase according to the ASMq ethanol extract
dose levels.
In summary, the present study demonstrated the
inhibitory eﬀect of ASMq ethanol extract on DMH-induced
rat coloncarcinogenesis. Ofcourse,as an herbal preparation,
ASMq ethanol extract contains a variety of compounds
such as alkaloids, ﬂavonoids, polysaccharides, terpenes as
well as coumarins (Yusup A, et al., unpublished data),
rather thansuggesting that chemopreventiveactionofASMq
ethanol extract may be attributed to the combined eﬀects of
various constituents rather than to any single component.Evidence-Based Complementary and Alternative Medicine 5
Suppression of mutagen-induced oncogenes expression and
cell cycle progression and direct modulation of DMH
metabolism might be associated to the chemopreventive
action of ASMq ethanol extract. Further investigations,
including studies elucidating the mechanism involved in its
antitumorigeniceﬀects,are warranted tofully evaluateactive
components for its chemopreventive properties.
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